Contract Manufacturing
Xcell Therapeutics opens an export route for cell therapy culture technology.
In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...
October 29, 2021 | News
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...
October 28, 2021 | News
Samsung Biologics Reports Third Quarter 2021 Financial Results
Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compa...
October 27, 2021 | News
BD launches its second center of excellence in flow cytometry for clinical research at CMC In India
The CoE at CMC Vellorewill help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis with highe...
October 25, 2021 | News
Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...
October 25, 2021 | News
Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy
Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...
October 13, 2021 | News
Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan
The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and pharmaceutical companies. The facili...
October 10, 2021 | News
Vetter/Syntegon partnership scores PDA Drug Delivery Innovation Award
With demand for niche and orphan drugs continuing to surge, Vetter and Syntegon recently synced their expertise to advance the industry’s approach to...
October 07, 2021 | News
CPhI Report predicts record EBITDAs for CDMOs in 2022
Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...
September 28, 2021 | News
Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021
Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...
September 23, 2021 | News
WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...
September 15, 2021 | News
GenScript ProBio to Manufacture Innovative Antibody Drug
FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...
September 06, 2021 | News
WuXi Biologics Received First Manufacturing License from Japan
WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...
September 02, 2021 | News
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate
This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...
August 03, 2021 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
